Based on a detailed profiling of the temporospatial expression pattern of OSM and LIF during myocardial healing in mice, we additionally demonstrate for the first time that a short-term, post-infarction delivery of recombinant hlOSM was superior compared to administration of mLIF or mOSM alone to improve cardiac architecture and contractility after MI. This evidence concerns the gene OSM and myocardial infarction.